Statins as immunomodulatory drugs.
Górski
A
A
Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Poland.
Kasprzycka
M
M
Nowaczyk
M
M
Wierzbicki
P
P
Korczak-Kowalska
G
G
Jezak
P
P
Kłosowska
D
D
Ekiert
A
A
Kłodos
K
K
D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002448:Cell Adhesion / Q000187:drug effects; D004730:Endothelium, Vascular / Q000276:immunology; D005109:Extracellular Matrix / Q000276:immunology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology; D008148:Lovastatin / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D019821:Simvastatin / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D008148:Lovastatin; D019821:Simvastatin